MARTINGALE ASSET MANAGEMENT L P - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 94 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 2.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARTINGALE ASSET MANAGEMENT L P ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q4 2021$197,000
-37.1%
36,9200.0%0.00%
-25.0%
Q3 2021$313,000
-14.9%
36,920
+22.6%
0.00%0.0%
Q2 2021$368,00030,1200.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$104,289,0004.42%
Boxer Capital, LLC 2,014,858$60,909,0002.10%
RA Capital Management 2,589,904$78,293,0001.43%
Artal Group S.A. 1,521,517$45,995,0001.12%
Ikarian Capital, LLC 358,941$10,851,0000.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$24,260,0000.59%
Bellevue Group AG 1,403,000$42,413,0000.59%
Logos Global Management LP 123,465$3,732,0000.48%
Casdin Capital, LLC 289,395$8,748,0000.39%
HighVista Strategies LLC 16,391$496,0000.36%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders